All Updates

ANNAPOLIS - Earlier today, Maryland’s Senate passed a bill that would prohibit those under 18 from using indoor tanning devices in the state. Yesterday, the House of Delegates passed the same legislation. Following is a statement from Jocelyn Collins, Maryland’s government relations director for the American Cancer Society Cancer Action

Columbus, OH. – March 15, 2019 – Today Gov. Mike DeWine released his proposed FY 2020-2021 budget for Ohio. Jeff Stephens, director of government relations in Ohio for the American Cancer Society Cancer Action Network (ACS CAN), made the following statement in reaction. “As an organization dedicated to saving lives,

Today, the Illinois State Senate sent a bill to Gov. J.B. Pritzker that raises the minimum age of tobacco sales to 21 years old. In response, Shana Crews, Illinois government relations director for the American Cancer Society Cancer Action Network, issued the following statement:

Washington, D.C. – The U.S. Food and Drug Administration (FDA) issued draft guidance this morning outlining steps it will take to address the public health crisis that has resulted from surging rates of youth use of tobacco products, a trend being largely driven by access to and use of flavored

An amendment filed Tuesday to House Bill 6 will severely undercut efforts to combat Big Tobacco in New Mexico, where more than 28 percent of all cancer deaths can be attributed to its products.

ACS CAN opposes tying access to affordable health coverage for low-income persons to work requirements because cancer patients, survivors and those who will be diagnosed with the disease could be physically unable to comply. Cancer treatment often causes several side effects, some of which can be serious and debilitating. Treating physicians may advise cancer patients against work during treatment to avoid risk of infection, to have time to heal and recover, and for other health reasons.

Washington, D.C. – The White House has announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current deputy director at NCI, will take over as acting director. Following is a